arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

download Export Data

Oaktree Specialty Lending Corp

OCSL

$12.36 ▼ -0.10 (-0.80%) at close

23 Visible periods

19 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Neutral

auto_awesome

Analytical Summary

Oaktree Specialty Lending Corp shows mixed fundamentals. Further due diligence is recommended before making investment decisions.

Market Cap $1.1B

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC —

FCF / Share $0.65 ↘

Trailing P/E 35.3x

Price / Book 0.8x

FCF Yield 5.3%

Debt / Equity 1.04

info Valuation on last close. End-of-day price, Sep 22, 2026.

23-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$30.94M

↓ -19.3% —

FCF / Share Free cash flow per share

$0.65

↓ -56.0% —

Long-Term Debt Long-term obligations

$1.44B

↓ -2.9% —

Health Breakdown

Returns ↓

Financial Health →

Cash Quality

Dividend History

Dividend / share · sourced from SEC filings

$0.40 Latest / share

FY 2018

FY 2019

FY 2020

FY 2021

FY 2022

FY 2023

FY 2024

$0.40

FY 2025

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	Q3 FY2026 Jun 30, 2026 10-Q ↗	Q2 FY2026 Mar 31, 2026 10-Q ↗	Q1 FY2026 Dec 31, 2025 10-Q ↗	Q4 FY2025 Nov 10, 2025 10-K ↗	Q3 FY2025 Jun 30, 2025 10-Q ↗	Q2 FY2025 Mar 31, 2025 10-Q ↗	Q1 FY2025 Dec 31, 2024 10-Q ↗	Q4 FY2024 Sep 30, 2024 10-K ↗	Q3 FY2024 Jun 30, 2024 10-Q ↗	Q2 FY2024 Mar 31, 2024 10-Q ↗	Q1 FY2024 Dec 31, 2023 10-Q ↗	Q4 FY2023 Sep 30, 2023 10-K ↗	Q3 FY2023 Jun 30, 2023 10-Q ↗	Q2 FY2023 Mar 31, 2023 10-Q ↗	Q1 FY2023 Dec 31, 2022 10-Q ↗	Q4 FY2022 Sep 30, 2022 10-K ↗	Q3 FY2022 Jun 30, 2022 10-Q ↗	Q2 FY2022 Mar 31, 2022 10-Q ↗	Q1 FY2022 Sep 30, 2021 10-Q ↗	Q4 FY2021 Sep 30, 2021 10-K ↗	Q4 FY2020 Sep 30, 2020 10-K ↗	Q4 FY2019 Sep 30, 2019 10-K ↗	Q4 FY2018 Sep 30, 2018 10-K ↗
EPS Growth YoY (%)	-20.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	50.0% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	-33.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-39.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	4300.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	-35.7% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-25.8% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-97.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-58.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-36.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	181.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	20.8% Good Good Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-19.3% Weak ↓ Weak Declining Year-over-year change in net income	47.9% Excellent ↓ Excellent Declining Year-over-year change in net income	-22.5% Weak ↓ Weak Declining Year-over-year change in net income	-33.4% Weak ↓ Weak Declining Year-over-year change in net income	3324.3% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	-31.3% Weak ↑ Weak Improving Year-over-year change in net income	-19.7% Weak ↑ Weak Improving Year-over-year change in net income	-96.9% Weak ↓ Weak Declining Year-over-year change in net income	-56.6% Weak ↓ Weak Declining Year-over-year change in net income	-20.0% Weak ↓ Weak Declining Year-over-year change in net income	247.9% Excellent Excellent Year-over-year change in net income	N/M	49.0% Excellent Excellent Year-over-year change in net income	—	—	—	—	—	—	—	—	—
FCF Growth YoY (%)	—	—	N/M	—	—	—	12010.7% Excellent Excellent Year-over-year change in free cash flow	—	—	—	N/M	—	—	—	—	—	—	—	—	—	—	—	—
EPS CAGR 3Y (%)	-10.0% Weak ↑ Weak Improving Compound annual EPS growth over 3 years	—	-35.2% Weak Weak Compound annual EPS growth over 3 years	8.4% Fair Fair Compound annual EPS growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q3 FY2026 Jun 30, 2026 10-Q ↗	Q2 FY2026 Mar 31, 2026 10-Q ↗	Q1 FY2026 Dec 31, 2025 10-Q ↗	Q4 FY2025 Nov 10, 2025 10-K ↗	Q3 FY2025 Jun 30, 2025 10-Q ↗	Q2 FY2025 Mar 31, 2025 10-Q ↗	Q1 FY2025 Dec 31, 2024 10-Q ↗	Q4 FY2024 Sep 30, 2024 10-K ↗	Q3 FY2024 Jun 30, 2024 10-Q ↗	Q2 FY2024 Mar 31, 2024 10-Q ↗	Q1 FY2024 Dec 31, 2023 10-Q ↗	Q4 FY2023 Sep 30, 2023 10-K ↗	Q3 FY2023 Jun 30, 2023 10-Q ↗	Q2 FY2023 Mar 31, 2023 10-Q ↗	Q1 FY2023 Dec 31, 2022 10-Q ↗	Q4 FY2022 Sep 30, 2022 10-K ↗	Q3 FY2022 Jun 30, 2022 10-Q ↗	Q2 FY2022 Mar 31, 2022 10-Q ↗	Q1 FY2022 Sep 30, 2021 10-Q ↗	Q4 FY2021 Sep 30, 2021 10-K ↗	Q4 FY2020 Sep 30, 2020 10-K ↗	Q4 FY2019 Sep 30, 2019 10-K ↗	Q4 FY2018 Sep 30, 2018 10-K ↗
FCF / Net Income (x)	1.86x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-6.92x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-14.88x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.05x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	19.89x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	2.59x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	0.11x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	5.31x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	—	2.15x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-8.34x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	5.01x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	-0.63x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—

🎯 Is capital allocation efficient? 1 metrics

Metric	Q3 FY2026 Jun 30, 2026 10-Q ↗	Q2 FY2026 Mar 31, 2026 10-Q ↗	Q1 FY2026 Dec 31, 2025 10-Q ↗	Q4 FY2025 Nov 10, 2025 10-K ↗	Q3 FY2025 Jun 30, 2025 10-Q ↗	Q2 FY2025 Mar 31, 2025 10-Q ↗	Q1 FY2025 Dec 31, 2024 10-Q ↗	Q4 FY2024 Sep 30, 2024 10-K ↗	Q3 FY2024 Jun 30, 2024 10-Q ↗	Q2 FY2024 Mar 31, 2024 10-Q ↗	Q1 FY2024 Dec 31, 2023 10-Q ↗	Q4 FY2023 Sep 30, 2023 10-K ↗	Q3 FY2023 Jun 30, 2023 10-Q ↗	Q2 FY2023 Mar 31, 2023 10-Q ↗	Q1 FY2023 Dec 31, 2022 10-Q ↗	Q4 FY2022 Sep 30, 2022 10-K ↗	Q3 FY2022 Jun 30, 2022 10-Q ↗	Q2 FY2022 Mar 31, 2022 10-Q ↗	Q1 FY2022 Sep 30, 2021 10-Q ↗	Q4 FY2021 Sep 30, 2021 10-K ↗	Q4 FY2020 Sep 30, 2020 10-K ↗	Q4 FY2019 Sep 30, 2019 10-K ↗	Q4 FY2018 Sep 30, 2018 10-K ↗
Return on Common Equity (%) (%)	2.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15%	-1.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15%	0.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15%	1.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15%	2.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15%	-2.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15%	0.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15%	2.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15%	0.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15%	0.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15%	0.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15%	3.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15%	2.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15%	1.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15%	1.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15%	1.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15%	-3.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15%	1.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15%	—	—	—	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q3 FY2026 Jun 30, 2026 10-Q ↗	Q2 FY2026 Mar 31, 2026 10-Q ↗	Q1 FY2026 Dec 31, 2025 10-Q ↗	Q4 FY2025 Nov 10, 2025 10-K ↗	Q3 FY2025 Jun 30, 2025 10-Q ↗	Q2 FY2025 Mar 31, 2025 10-Q ↗	Q1 FY2025 Dec 31, 2024 10-Q ↗	Q4 FY2024 Sep 30, 2024 10-K ↗	Q3 FY2024 Jun 30, 2024 10-Q ↗	Q2 FY2024 Mar 31, 2024 10-Q ↗	Q1 FY2024 Dec 31, 2023 10-Q ↗	Q4 FY2023 Sep 30, 2023 10-K ↗	Q3 FY2023 Jun 30, 2023 10-Q ↗	Q2 FY2023 Mar 31, 2023 10-Q ↗	Q1 FY2023 Dec 31, 2022 10-Q ↗	Q4 FY2022 Sep 30, 2022 10-K ↗	Q3 FY2022 Jun 30, 2022 10-Q ↗	Q2 FY2022 Mar 31, 2022 10-Q ↗	Q1 FY2022 Sep 30, 2021 10-Q ↗	Q4 FY2021 Sep 30, 2021 10-K ↗	Q4 FY2020 Sep 30, 2020 10-K ↗	Q4 FY2019 Sep 30, 2019 10-K ↗	Q4 FY2018 Sep 30, 2018 10-K ↗
Debt to Equity (x)	1.04x Caution → Caution Stable Total debt relative to shareholder equity Optimal: < 0.6x	1.07x Caution → Caution Stable Total debt relative to shareholder equity Optimal: < 0.6x	1.12x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x	1.01x Caution → Caution Stable Total debt relative to shareholder equity Optimal: < 0.6x	0.98x Fair ↓ Fair Declining Total debt relative to shareholder equity Optimal: < 0.6x	0.98x Fair ↓ Fair Declining Total debt relative to shareholder equity Optimal: < 0.6x	1.09x Caution → Caution Stable Total debt relative to shareholder equity Optimal: < 0.6x	1.10x Caution → Caution Stable Total debt relative to shareholder equity Optimal: < 0.6x	1.13x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x	1.07x Caution → Caution Stable Total debt relative to shareholder equity Optimal: < 0.6x	1.07x Caution Caution Total debt relative to shareholder equity Optimal: < 0.6x	—	1.15x Caution Caution Total debt relative to shareholder equity Optimal: < 0.6x	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$1.40B	$1.43B	$1.53B	$1.41B	$1.37B	$1.35B	$1.46B	$1.57B	$1.60B	$1.51B	$1.51B	$-136.45M	$1.68B	—	—	$-23.53M	—	—	—	$-29.33M	—	—	—

📊 What does each share earn? 7 metrics

Metric	Q3 FY2026 Jun 30, 2026 10-Q ↗	Q2 FY2026 Mar 31, 2026 10-Q ↗	Q1 FY2026 Dec 31, 2025 10-Q ↗	Q4 FY2025 Nov 10, 2025 10-K ↗	Q3 FY2025 Jun 30, 2025 10-Q ↗	Q2 FY2025 Mar 31, 2025 10-Q ↗	Q1 FY2025 Dec 31, 2024 10-Q ↗	Q4 FY2024 Sep 30, 2024 10-K ↗	Q3 FY2024 Jun 30, 2024 10-Q ↗	Q2 FY2024 Mar 31, 2024 10-Q ↗	Q1 FY2024 Dec 31, 2023 10-Q ↗	Q4 FY2023 Sep 30, 2023 10-K ↗	Q3 FY2023 Jun 30, 2023 10-Q ↗	Q2 FY2023 Mar 31, 2023 10-Q ↗	Q1 FY2023 Dec 31, 2022 10-Q ↗	Q4 FY2022 Sep 30, 2022 10-K ↗	Q3 FY2022 Jun 30, 2022 10-Q ↗	Q2 FY2022 Mar 31, 2022 10-Q ↗	Q1 FY2022 Sep 30, 2021 10-Q ↗	Q4 FY2021 Sep 30, 2021 10-K ↗	Q4 FY2020 Sep 30, 2020 10-K ↗	Q4 FY2019 Sep 30, 2019 10-K ↗	Q4 FY2018 Sep 30, 2018 10-K ↗
Basic EPS, GAAP (USD)	$0.35	$-0.21	$0.06	$0.28	$0.44	$-0.42	$0.09	$0.46	$0.01	$0.12	$0.14	$0.62	$0.48	$0.29	$0.22	$0.22	$-0.62	$0.24	—	—	—	—	—
Free Cash Flow per Share (USD)	$0.65	$1.48	$-0.95	—	—	—	$1.75	—	—	—	$0.01	—	—	$0.63	$-1.80	—	$0.39	—	—	—	—	—	—
Dividend per Share (USD)	—	—	—	$0.40	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$15.70	$15.69	$16.30	$16.64	$16.76	$16.75	$17.63	$18.09	$18.19	$18.72	$19.14	$19.63	$19.58	$19.66	$19.63	$20.38	$20.67	$21.79	$21.84	$21.84	$19.47	—	—
Tangible Book Value per Share (USD)	$15.70	$15.69	$16.30	$16.64	$16.76	$16.75	$17.63	$18.09	$18.19	$18.72	$19.14	$19.63	$19.58	$19.66	$19.63	$20.38	$20.67	$21.79	$21.84	$21.84	$19.47	—	—
Basic Weighted Avg Shares (shares)	88.09M	88.09M	88.09M	—	88.09M	85.92M	82.25M	—	81.83M	79.76M	77.84M	—	77.08M	73.20M	61.14M	—	61.12M	60.53M	—	—	—	—	—
Dividend Payout Ratio (%)	—	—	—	142.9% Weak Weak Dividends paid as a percentage of earnings Optimal: 30-60%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q3 FY2026 Jun 30, 2026 10-Q ↗	Q2 FY2026 Mar 31, 2026 10-Q ↗	Q1 FY2026 Dec 31, 2025 10-Q ↗	Q4 FY2025 Nov 10, 2025 10-K ↗	Q3 FY2025 Jun 30, 2025 10-Q ↗	Q2 FY2025 Mar 31, 2025 10-Q ↗	Q1 FY2025 Dec 31, 2024 10-Q ↗	Q4 FY2024 Sep 30, 2024 10-K ↗	Q3 FY2024 Jun 30, 2024 10-Q ↗	Q2 FY2024 Mar 31, 2024 10-Q ↗	Q1 FY2024 Dec 31, 2023 10-Q ↗	Q4 FY2023 Sep 30, 2023 10-K ↗	Q3 FY2023 Jun 30, 2023 10-Q ↗	Q2 FY2023 Mar 31, 2023 10-Q ↗	Q1 FY2023 Dec 31, 2022 10-Q ↗	Q4 FY2022 Sep 30, 2022 10-K ↗	Q3 FY2022 Jun 30, 2022 10-Q ↗	Q2 FY2022 Mar 31, 2022 10-Q ↗	Q1 FY2022 Sep 30, 2021 10-Q ↗	Q4 FY2021 Sep 30, 2021 10-K ↗	Q4 FY2020 Sep 30, 2020 10-K ↗	Q4 FY2019 Sep 30, 2019 10-K ↗	Q4 FY2018 Sep 30, 2018 10-K ↗
LT Debt (USD)	$1.44B	$1.48B	$1.61B	$1.49B	$1.45B	$1.45B	$1.58B	$1.64B	$1.70B	$1.64B	$1.62B	—	$1.74B	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$1.38B	$1.38B	$1.44B	$1.47B	$1.48B	$1.48B	$1.45B	$1.49B	$1.50B	$1.52B	$1.51B	$1.52B	$1.51B	$1.52B	$1.20B	$1.25B	$1.26B	$1.33B	$1.31B	$1.31B	$914.88M	—	—

📋 What is driving earnings? 2 metrics

Metric	Q3 FY2026 Jun 30, 2026 10-Q ↗	Q2 FY2026 Mar 31, 2026 10-Q ↗	Q1 FY2026 Dec 31, 2025 10-Q ↗	Q4 FY2025 Nov 10, 2025 10-K ↗	Q3 FY2025 Jun 30, 2025 10-Q ↗	Q2 FY2025 Mar 31, 2025 10-Q ↗	Q1 FY2025 Dec 31, 2024 10-Q ↗	Q4 FY2024 Sep 30, 2024 10-K ↗	Q3 FY2024 Jun 30, 2024 10-Q ↗	Q2 FY2024 Mar 31, 2024 10-Q ↗	Q1 FY2024 Dec 31, 2023 10-Q ↗	Q4 FY2023 Sep 30, 2023 10-K ↗	Q3 FY2023 Jun 30, 2023 10-Q ↗	Q2 FY2023 Mar 31, 2023 10-Q ↗	Q1 FY2023 Dec 31, 2022 10-Q ↗	Q4 FY2022 Sep 30, 2022 10-K ↗	Q3 FY2022 Jun 30, 2022 10-Q ↗	Q2 FY2022 Mar 31, 2022 10-Q ↗	Q1 FY2022 Sep 30, 2021 10-Q ↗	Q4 FY2021 Sep 30, 2021 10-K ↗	Q4 FY2020 Sep 30, 2020 10-K ↗	Q4 FY2019 Sep 30, 2019 10-K ↗	Q4 FY2018 Sep 30, 2018 10-K ↗
Net Income, GAAP (USD)	$30.94M	$-18.89M	$5.61M	$24.58M	$38.35M	$-36.25M	$7.24M	$36.91M	$1.12M	$9.34M	$10.54M	$45.95M	$36.69M	$21.52M	$13.17M	$13.21M	$-37.83M	$14.44M	—	—	—	—	—
Operating Cash Flow (USD)	$57.56M	$130.69M	$-83.45M	$1.33M	—	—	$143.96M	$95.51M	—	—	$1.12M	$243.78M	—	$46.18M	$-109.90M	$66.23M	$23.70M	—	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 8 years · 23 quarters

Oaktree Specialty Lending Corp

Analytical Summary

23-Year Financial Trajectory

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Percentile Rankings

Compare OCSL with peers